Literature DB >> 29805043

Heterozygous Truncating Variants in POMP Escape Nonsense-Mediated Decay and Cause a Unique Immune Dysregulatory Syndrome.

M Cecilia Poli1, Frédéric Ebstein2, Sarah K Nicholas3, Marietta M de Guzman3, Lisa R Forbes4, Ivan K Chinn3, Emily M Mace3, Tiphanie P Vogel3, Alexandre F Carisey3, Felipe Benavides5, Zeynep H Coban-Akdemir6, Richard A Gibbs7, Shalini N Jhangiani8, Donna M Muzny8, Claudia M B Carvalho6, Deborah A Schady9, Mahim Jain6, Jill A Rosenfeld6, Lisa Emrick10, Richard A Lewis11, Brendan Lee6, Barbara A Zieba2, Sébastien Küry12, Elke Krüger2, James R Lupski13, Bret L Bostwick14, Jordan S Orange15.   

Abstract

The proteasome processes proteins to facilitate immune recognition and host defense. When inherently defective, it can lead to aberrant immunity resulting in a dysregulated response that can cause autoimmunity and/or autoinflammation. Biallelic or digenic loss-of-function variants in some of the proteasome subunits have been described as causing a primary immunodeficiency disease that manifests as a severe dysregulatory syndrome: chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE). Proteasome maturation protein (POMP) is a chaperone for proteasome assembly and is critical for the incorporation of catalytic subunits into the proteasome. Here, we characterize and describe POMP-related autoinflammation and immune dysregulation disease (PRAID) discovered in two unrelated individuals with a unique constellation of early-onset combined immunodeficiency, inflammatory neutrophilic dermatosis, and autoimmunity. We also begin to delineate a complex genetic mechanism whereby de novo heterozygous frameshift variants in the penultimate exon of POMP escape nonsense-mediated mRNA decay (NMD) and result in a truncated protein that perturbs proteasome assembly by a dominant-negative mechanism. To our knowledge, this mechanism has not been reported in any primary immunodeficiencies, autoinflammatory syndromes, or autoimmune diseases. Here, we define a unique hypo- and hyper-immune phenotype and report an immune dysregulation syndrome caused by frameshift mutations that escape NMD.
Copyright © 2018 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PID; POMP; POMP-related autoinflammation and immune dysregulation disease; PRAID; autoinflammatory syndrome; core particle proteasome 20S; dominant negative; interferonopathy; nonsense-mediated decay; primary immune deficiency

Mesh:

Substances:

Year:  2018        PMID: 29805043      PMCID: PMC5992134          DOI: 10.1016/j.ajhg.2018.04.010

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  50 in total

1.  PAC1 gene knockout reveals an essential role of chaperone-mediated 20S proteasome biogenesis and latent 20S proteasomes in cellular homeostasis.

Authors:  Katsuhiro Sasaki; Jun Hamazaki; Masato Koike; Yuko Hirano; Masaaki Komatsu; Yasuo Uchiyama; Keiji Tanaka; Shigeo Murata
Journal:  Mol Cell Biol       Date:  2010-05-24       Impact factor: 4.272

2.  DVL3 Alleles Resulting in a -1 Frameshift of the Last Exon Mediate Autosomal-Dominant Robinow Syndrome.

Authors:  Janson J White; Juliana F Mazzeu; Alexander Hoischen; Yavuz Bayram; Marjorie Withers; Alper Gezdirici; Virginia Kimonis; Marloes Steehouwer; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; Bregje W M van Bon; V Reid Sutton; James R Lupski; Han G Brunner; Claudia M B Carvalho
Journal:  Am J Hum Genet       Date:  2016-02-25       Impact factor: 11.025

3.  Characterisation of the newly identified human Ump1 homologue POMP and analysis of LMP7(beta 5i) incorporation into 20 S proteasomes.

Authors:  E Witt; D Zantopf; M Schmidt; R Kraft; P M Kloetzel; E Krüger
Journal:  J Mol Biol       Date:  2000-08-04       Impact factor: 5.469

4.  REST Final-Exon-Truncating Mutations Cause Hereditary Gingival Fibromatosis.

Authors:  Yavuz Bayram; Janson J White; Nursel Elcioglu; Megan T Cho; Neda Zadeh; Asuman Gedikbasi; Sukru Palanduz; Sukru Ozturk; Kivanc Cefle; Ozgur Kasapcopur; Zeynep Coban Akdemir; Davut Pehlivan; Amber Begtrup; Claudia M B Carvalho; Ingrid Sophie Paine; Ali Mentes; Kivanc Bektas-Kayhan; Ender Karaca; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; James R Lupski
Journal:  Am J Hum Genet       Date:  2017-07-06       Impact factor: 11.025

5.  Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop.

Authors:  Janos Steffen; Michael Seeger; Annett Koch; Elke Krüger
Journal:  Mol Cell       Date:  2010-10-08       Impact factor: 17.970

Review 6.  The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.

Authors:  Kalpana Manthiram; Qing Zhou; Ivona Aksentijevich; Daniel L Kastner
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

7.  De Novo Truncating Mutations in the Last and Penultimate Exons of PPM1D Cause an Intellectual Disability Syndrome.

Authors:  Sandra Jansen; Sinje Geuer; Rolph Pfundt; Rachel Brough; Priyanka Ghongane; Johanna C Herkert; Elysa J Marco; Marjolein H Willemsen; Tjitske Kleefstra; Mark Hannibal; Joseph T Shieh; Sally Ann Lynch; Frances Flinter; David R FitzPatrick; Alice Gardham; Birgitta Bernhard; Nicola Ragge; Ruth Newbury-Ecob; Raphael Bernier; Malin Kvarnung; E A Helena Magnusson; Marja W Wessels; Marjon A van Slegtenhorst; Kristin G Monaghan; Petra de Vries; Joris A Veltman; Christopher J Lord; Lisenka E L M Vissers; Bert B A de Vries
Journal:  Am J Hum Genet       Date:  2017-03-23       Impact factor: 11.025

Review 8.  The role of the proteasome in the generation of MHC class I ligands and immune responses.

Authors:  E J A M Sijts; P M Kloetzel
Journal:  Cell Mol Life Sci       Date:  2011-03-09       Impact factor: 9.261

9.  siRNA silencing of proteasome maturation protein (POMP) activates the unfolded protein response and constitutes a model for KLICK genodermatosis.

Authors:  Johanna Dahlqvist; Hans Törmä; Jitendra Badhai; Niklas Dahl
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

10.  Exome sequencing resolves apparent incidental findings and reveals further complexity of SH3TC2 variant alleles causing Charcot-Marie-Tooth neuropathy.

Authors:  James R Lupski; Claudia Gonzaga-Jauregui; Yaping Yang; Matthew N Bainbridge; Shalini Jhangiani; Christian J Buhay; Christie L Kovar; Min Wang; Alicia C Hawes; Jeffrey G Reid; Christine Eng; Donna M Muzny; Richard A Gibbs
Journal:  Genome Med       Date:  2013-06-27       Impact factor: 11.117

View more
  47 in total

Review 1.  Toward a better understanding of type I interferonopathies: a brief summary, update and beyond.

Authors:  Zhong-Xun Yu; Hong-Mei Song
Journal:  World J Pediatr       Date:  2019-08-03       Impact factor: 2.764

Review 2.  Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases.

Authors:  Ivona Aksentijevich; Oskar Schnappauf
Journal:  Nat Rev Rheumatol       Date:  2021-05-25       Impact factor: 20.543

3.  Novel proteasome assembly chaperone mutations in PSMG2/PAC2 cause the autoinflammatory interferonopathy CANDLE/PRAAS4.

Authors:  Adriana A de Jesus; Anja Brehm; Rachel VanTries; Pascal Pillet; Anne-Sophie Parentelli; Gina A Montealegre Sanchez; Zuoming Deng; Isabelle Koné Paut; Raphaela Goldbach-Mansky; Elke Krüger
Journal:  J Allergy Clin Immunol       Date:  2019-01-18       Impact factor: 10.793

4.  Identifying Genes Whose Mutant Transcripts Cause Dominant Disease Traits by Potential Gain-of-Function Alleles.

Authors:  Zeynep Coban-Akdemir; Janson J White; Xiaofei Song; Shalini N Jhangiani; Jawid M Fatih; Tomasz Gambin; Yavuz Bayram; Ivan K Chinn; Ender Karaca; Jaya Punetha; Cecilia Poli; Eric Boerwinkle; Chad A Shaw; Jordan S Orange; Richard A Gibbs; Tuuli Lappalainen; James R Lupski; Claudia M B Carvalho
Journal:  Am J Hum Genet       Date:  2018-07-19       Impact factor: 11.025

Review 5.  Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach.

Authors:  Peter A Nigrovic; Pui Y Lee; Hal M Hoffman
Journal:  J Allergy Clin Immunol       Date:  2020-11       Impact factor: 10.793

Review 6.  Moving towards a systems-based classification of innate immune-mediated diseases.

Authors:  Sinisa Savic; Emily A Caseley; Michael F McDermott
Journal:  Nat Rev Rheumatol       Date:  2020-02-27       Impact factor: 20.543

7.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

Review 8.  Targeted Therapy with Biologicals and Small Molecules in Primary Immunodeficiencies.

Authors:  Ottavia Maria Delmonte; Luigi Daniele Notarangelo
Journal:  Med Princ Pract       Date:  2019-10-10       Impact factor: 1.927

Review 9.  [Genetic diagnostics of autoinflammatory diseases].

Authors:  Oskar Schnappauf
Journal:  Z Rheumatol       Date:  2020-09       Impact factor: 1.372

10.  Cohort Study of Nonmelanoma Skin Cancer and the Risk of Exfoliation Glaucoma.

Authors:  Jae H Kang; Trang VoPham; Francine Laden; Bernard A Rosner; Barbara Wirostko; Robert Ritch; Janey L Wiggs; Abrar Qureshi; Hongmei Nan; Louis R Pasquale
Journal:  J Glaucoma       Date:  2020-06       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.